Literature DB >> 21778689

Decrease in high human chorionic gonadotropin in twin-twin transfusion syndrome following fetoscopic laser surgery.

Masachi Hanaoka1, Satoshi Hayashi, Mari Saito, Mineto Morita, Haruhiko Sago.   

Abstract

INTRODUCTION: The purpose of this study was to investigate the concentration of maternal serum human chorionic gonadotropin (hCG) in twin-twin transfusion syndrome (TTTS) before and after fetoscopic laser surgery and to clarify the association between TTTS and hCG.
MATERIAL AND METHODS: The concentration of maternal serum hCG was measured before fetoscopic laser surgery and 2 and 4 weeks after laser surgery in 120 patients diagnosed with TTTS.
RESULTS: The preoperative serum concentration of hCG was 6.34 multiples of the median (MoM; interquartile range 3.52-9.86). The concentration of hCG was higher in TTTS of Quintero stage III or IV (7.17 MoM, range 4.21-11.0) compared to stage I or II (3.37 MoM, range 2.35-7.74). When laser surgery for TTTS was effective, hCG gradually decreased to less than half the preoperative concentration 2 weeks after laser surgery, and the concentration was further reduced to within the normal range at 4 weeks. However, the concentration of hCG in 3 cases with TTTS recurrence did not decrease. DISCUSSION: A close association was observed between the concentration of hCG and the condition of TTTS. A change in the concentration of hCG after laser surgery could be a useful marker to judge the effectiveness of laser surgery in TTTS.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778689     DOI: 10.1159/000328456

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  1 in total

1.  Relapse of Human Chorionic Gonadotropin-Induced Hyperthyroidism and Severe Hyperemesis Gravidarum Secondary to Twin-Twin Transfusion Syndrome, With Rapid Recovery Following Fetoscopic Laser Coagulation: Case Report.

Authors:  Faiza Lamine; Chiara Camponovo; David Baud; Dominique Werner; Laura Marino; Gerasimos P Sykiotis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.